Advertisement

Topics

Antibe Therapeutics Looking for More Licensing Deals

19:00 EDT 17 May 2018 | Investing News Network

Antibe Therapeutics is trying to change the game of non-steroidal anti-inflammatory drugs (NSAID)—the “largest category of drugs globally,” CEO Dan Legault told INN.

The post Antibe Therapeutics Looking for More Licensing Deals appeared first on Investing News Network.

Original Article: Antibe Therapeutics Looking for More Licensing Deals

NEXT ARTICLE

More From BioPortfolio on "Antibe Therapeutics Looking for More Licensing Deals"

Advertisement
Quick Search
Advertisement
Advertisement